Does AZD-1222 Cause Mobility decreased? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Mobility decreased have been filed in association with AZD-1222. This represents 1.0% of all adverse event reports for AZD-1222.
24
Reports of Mobility decreased with AZD-1222
1.0%
of all AZD-1222 reports
0
Deaths
14
Hospitalizations
How Dangerous Is Mobility decreased From AZD-1222?
Of the 24 reports, 14 (58.3%) required hospitalization, and 1 (4.2%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZD-1222. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does AZD-1222 Cause?
Headache (838)
Fatigue (784)
Pyrexia (735)
Pain (579)
Covid-19 (515)
Arthralgia (508)
Nausea (494)
Palpitations (485)
Dyspnoea (472)
Abdominal discomfort (467)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which AZD-1222 Alternatives Have Lower Mobility decreased Risk?
AZD-1222 vs AZELAIC ACID
AZD-1222 vs AZELASTINE
AZD-1222 vs AZELASTINE\FLUTICASONE
AZD-1222 vs AZELNIDIPINE
AZD-1222 vs AZILECT